HIV and ID Observations

May 31st, 2025

How ID Doctors Get Paid, Part 2: Infection Control and Other Invaluable (but Often Invisible) Work

Before getting to today’s main topic, allow me a brief protest — three recent vaccine-related actions that reek of profound (and misguided) vaccine distrust from HHS leadership. They are: Cancellation of a grant to develop an H5N1 vaccine. Preparation for this looming pandemic threat is critical, and there’s arguably no better way than having a […]

---

May 22nd, 2025

The Pros and Cons of the Latest FDA Actions on COVID Vaccines

In case you missed it, last week the FDA granted full approval for the Novavax COVID-19 vaccine. This vaccine, which uses a more traditional protein-plus-adjuvant strategy instead of the mRNA approach of Pfizer and Moderna, is no longer in “Emergency Use Authorization (EUA)” limbo. Here’s what that means in practical terms: It shows the data […]

---

May 18th, 2025

How ID Doctors Get Paid — The Bread, Butter, and Budget Deficits of Infectious Diseases

Two decades ago, Dr. Atul Gawande wrote a memorable piece for The New Yorker about how doctors in the United States get paid. Providing a nice mix of self-reflection about his own experience and some skillful reporting, he described the challenging process of figuring out what he, a newly hired surgeon, should earn for a […]

---

May 7th, 2025

FDA’s Latest Appointment Is … Interesting

Those of us who follow infectious diseases and vaccine science closely (OK, obsessively) know that the FDA’s Center for Biologics Evaluation and Research (CBER) plays an enormous role in public health. Vaccines, gene therapies, monoclonal antibodies, blood products — all pass through CBER on their path to approval. During the COVID-19 pandemic, this center became […]

---